文献速递其他结缔组织病

18F-FDG PET-CT 诊断原发性干燥综合征相关淋巴瘤的价值

Usefulness of 18 F-Labeled Fluorodeoxyglucose-Positron Emission Tomography for the Diagnosis of Lymphoma in Primary Sjögren's Syndrome.
PubMed 文献 · Arthritis Rheumatol · 2019-05-14

该多中心回顾性研究纳入 45 例符合 ACR/EULAR 2016 原发性干燥综合征标准且接受 PET-CT 的患者,其中 15 例合并淋巴瘤。淋巴瘤患者腮腺平均大小(P=0.048)与 SUVmax(P=0.001)更高,局灶性肺部摄取更常见(33.3% 对 3.3%,P=0.01);腮腺 SUVmax≥4.7 和/或局灶性肺病变提示淋巴瘤(敏感度 80%,特异度 83.3%)。

要点

  • 腮腺 SUVmax≥4.7 和/或局灶性肺病变对原发性干燥综合征合并淋巴瘤有提示价值。
  • 淋巴结 FDG 摄取在有无淋巴瘤患者间频率相近,鉴别价值有限。
  • 淋巴瘤患者腮腺大小与 SUVmax 均高于无淋巴瘤者。

核心结论

  • 腮腺 SUVmax≥4.7 和/或存在局灶性肺部病变与原发性干燥综合征患者淋巴瘤诊断相关。
  • 淋巴结与腮腺受累在有无淋巴瘤的干燥综合征患者中均常见且频率相似。

研究设计与样本

  • 两中心回顾性研究,纳入符合 ACR/EULAR 2016 原发性干燥综合征标准且接受 PET-CT 的患者 45 例,其中 15 例患淋巴瘤。
  • 由两名对淋巴瘤诊断设盲的独立读者分析 PET-CT 图像,比较有无淋巴瘤患者的异常表现。

主要发现

  • 淋巴瘤患者腮腺平均大小大于无淋巴瘤者(P=0.048),腮腺 SUVmax 亦更高(P=0.001)。
  • 淋巴结 FDG 摄取见于 53.3% 的淋巴瘤患者与 43.3% 的无淋巴瘤患者,部位数量、摄取模式与平均 SUVmax 均无差异。
  • 局灶性肺部摄取(结节或实变)见于 5 例淋巴瘤患者(33.3%)与 1 例无淋巴瘤患者(3.3%)(P=0.01)。

关键数值与推荐

  • 腮腺 SUVmax≥4.7 和/或存在局灶性肺部病变提示淋巴瘤,敏感度 80%,特异度 83.3%。
  • 研究对象为符合 ACR/EULAR 2016 原发性干燥综合征标准并接受 PET-CT 的患者。

临床怎么用

  • 对原发性干燥综合征患者评估淋巴瘤风险时,可关注腮腺 SUVmax≥4.7 及局灶性肺部病变。
  • 淋巴结 FDG 摄取本身在有无淋巴瘤患者中均常见,不宜单独据此判断。

局限性

  • 为两中心回顾性研究,样本量 45 例、淋巴瘤 15 例,结果需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The usefulness of positron emission tomography-computed tomography (PET-CT) with 18 F-labeled fluorodeoxyglucose (18 F-FDG) for the diagnosis of lymphoma in patients with primary Sjögren's syndrome (SS) is unclear, since the abnormalities it reveals may be due to systemic manifestations of SS. This study was undertaken to compare 18 F-FDG-PET-CT in patients with primary SS with lymphoma and those without lymphoma in order to identify patterns associated with lymphoma. METHODS: A retrospective study was conducted in 2 centers and included patients who met the American College of Rheumatology/European League Against Rheumatism 2016 criteria for primary SS and had undergone PET-CT. Two independent readers who were blinded with regard to lymphoma diagnosis analyzed PET-CT scans. Abnormalities were compared between patients with and those without lymphoma. RESULTS: Of the 45 patients included, 15 had lymphoma. Compared to patients without lymphoma, the mean size (P = 0.048) and maximum standardized uptake value (SUVmax) (P = 0.001) of the parotid glands were higher in patients with lymphoma. FDG uptake in the lymph nodes was observed in 53.3% of the patients with lymphoma and 43.3% of the patients without lymphoma, with no difference in the number of sites, uptake pattern, or mean SUVmax. Focal pulmonary uptake (nodules or condensations) was observed in 5 of the patients with lymphoma (33.3%) but only 1 patient without lymphoma (3.3%) (P = 0.01). Having an SUVmax in the parotid gland of ≥4.7 and/or the presence of focal pulmonary lesions was highly suggestive of lymphoma (sensitivity 80%, specificity 83.3%). CONCLUSION: Some systemic manifestations of primary SS (lymphadenopathy, pulmonary involvement, and salivary gland involvement) can be visualized by PET-CT. Involvement of the lymph nodes and parotid glands is commonly observed with a similar frequency in SS patients with and those without lymphoma. An SUVmax in the parotid glands of ≥4.7 and/or the presence of focal lung lesions are associated with the diagnosis of lymphoma.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Keraen J, Blanc E, Besson FL, et al. Usefulness of 18 F-Labeled Fluorodeoxyglucose-Positron Emission Tomography for the Diagnosis of Lymphoma in Primary Sjögren's Syndrome. Arthritis Rheumatol. 2019. PMID: 30615273. doi:10.1002/art.40829

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。